Zobrazeno 1 - 3
of 3
pro vyhledávání: '"David Dunnington"'
Autor:
Shailender Bhatia, Griselda Zuccarino-Catania, Suzanne McGettigan, Matthew A. Lunning, Jordan P. McPherson, Ryan M. Weight, Matthew J. Frigault, Jeffrey A. Sosman, Scott Shofer, John A. Thompson, Stephanie Andrews, Anita M. Engh, Nathan A. Pennell, Sunil Reddy, Nisha Mohindra, Alyse Johnson-Chilla, Jarushka Naidoo, Luciano J. Costa, Bryan J. Schneider, Sandip Pravin Patel, Marc S. Ernstoff, Lihua E. Budde, Philippe Armand, Marianne Davies, Yinghong Wang, Bianca Santomasso, Mabel Ryder, Benjamin H. Kaffenberger, Anthony J. Olszanski, Julie R. Brahmer, Olalekan O. Oluwole, David Dunnington
Publikováno v:
Journal of the National Comprehensive Cancer Network. 18:230-241
The NCCN Guidelines for Management of Immunotherapy-Related Toxicities provide interdisciplinary guidance on the management of immune-related adverse events (irAEs) resulting from cancer immunotherapy. These NCCN Guidelines Insights describe symptoms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2dc680cd7f3052f12230fb477633ac02
https://doi.org/10.6004/jnccn.2020.0012
https://doi.org/10.6004/jnccn.2020.0012
Autor:
Lihua E. Budde, Philippe Armand, Bianca Santomasso, Marianne Davies, Shailender Bhatia, Christopher J. Hoimes, Jillian L. Scavone, Bryan J. Schneider, Brianna Hoffner, Jeffrey A. Sosman, Yinghong Wang, Nisha Mohindra, Jarushka Naidoo, Momen M. Wahidi, Mabel Ryder, Stephanie Andrews, Matthew J. Frigault, Marc S. Ernstoff, Olalekan O. Oluwole, Julie R. Brahmer, Alyse Johnson-Chilla, Sunil Reddy, Anthony J. Olszanski, Luciano J. Costa, Scott Shofer, John A. Thompson, Mario E. Lacouture, David Dunnington, Sandip Pravin Patel, Frederick L. Locke, Matthew A. Lunning
Publikováno v:
Journal of the National Comprehensive Cancer Network. 17:255-289
The aim of the NCCN Guidelines for Management of Immunotherapy-Related Toxicities is to provide guidance on the management of immune-related adverse events resulting from cancer immunotherapy. The NCCN Management of Immunotherapy-Related Toxicities P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d85ea30eb664a6b2b11c57f4d7e6737
https://doi.org/10.6004/jnccn.2019.0013
https://doi.org/10.6004/jnccn.2019.0013
Autor:
John A, Thompson, Bryan J, Schneider, Julie, Brahmer, Stephanie, Andrews, Philippe, Armand, Shailender, Bhatia, Lihua E, Budde, Luciano, Costa, Marianne, Davies, David, Dunnington, Marc S, Ernstoff, Matthew, Frigault, Brianna, Hoffner, Christopher J, Hoimes, Mario, Lacouture, Frederick, Locke, Matthew, Lunning, Nisha A, Mohindra, Jarushka, Naidoo, Anthony J, Olszanski, Olalekan, Oluwole, Sandip P, Patel, Sunil, Reddy, Mabel, Ryder, Bianca, Santomasso, Scott, Shofer, Jeffrey A, Sosman, Momen, Wahidi, Yinghong, Wang, Alyse, Johnson-Chilla, Jillian L, Scavone
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 17(3)
The aim of the NCCN Guidelines for Management of Immunotherapy-Related Toxicities is to provide guidance on the management of immune-related adverse events resulting from cancer immunotherapy. The NCCN Management of Immunotherapy-Related Toxicities P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8f56c27da2afba3617c49274dafa02bb
https://pubmed.ncbi.nlm.nih.gov/30865922
https://pubmed.ncbi.nlm.nih.gov/30865922